Stay updated on Benralizumab in Hypereosinophilic Syndrome Clinical Trial

Sign up to get notified when there's something new on the Benralizumab in Hypereosinophilic Syndrome Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Benralizumab in Hypereosinophilic Syndrome Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The page now renders a 403 Forbidden error page with basic HTML boilerplate and a Home link. This change replaces the previous study record content with an access-denied notice.
    Difference
    19%
    Check dated 2026-09-23T01:22:52.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision: v3.7.0 is now displayed, replacing Revision: v3.6.6. This reflects a metadata version update for the page rather than a substantive change to the study information.
    Difference
    0.1%
    Check dated 2026-09-16T00:29:25.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6, indicating a new deployment of the page's underlying software.
    Difference
    0.1%
    Check dated 2026-09-01T20:29:34.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.4 to v3.6.5, indicating a small update to the page's packaging or backend; it does not modify the study information or how the page is used.
    Difference
    0.1%
    Check dated 2026-08-11T19:04:46.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.3 to v3.6.4, signaling a backend update to the page. The change does not alter visible study content or user-facing features.
    Difference
    0.1%
    Check dated 2026-07-28T13:44:42.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    - Adds a new publication reference to the Publications section for a study on benralizumab in PDGFRA-negative hypereosinophilic syndrome, including authors, title, journal, and DOI. - This provides broader literature context on the drug and condition within the study record.
    Difference
    0.1%
    Check dated 2026-07-14T08:47:08.000Z thumbnail image

Stay in the know with updates to Benralizumab in Hypereosinophilic Syndrome Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Benralizumab in Hypereosinophilic Syndrome Clinical Trial page.